ArticleJournal of pharmacopuncture2025
Design, Optimization, and Analytical Performance Evaluation of LAMP-Based Rapid Detection Assay for Severe Fever with Thrombocytopenia Syndrome Virus.
Article in Journal of pharmacopuncture, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), a tick-borne pathogen, presents a growing public health threat in East Asia. Although conventional RT-PCR methods are effective for detection, they are limited by the need for specialized equipment and time-consuming procedures. This study aimed to develop and evaluate a rapid, sensitive, and field-deployable diagnostic method for SFTSV using Loop-Mediated Isothermal Amplification (LAMP). Methods: Twelve sets of LAMP primers were designed to target the RNA-dependent RNA polymerase (L segment) of the SFTSV genome. These primers were screened through stepwise colorimetric LAMP assays to identify the optimal set. The sensitivity and specificity of the selected primer set were evaluated using serial dilutions of SFTSV RNA and a panel of control pathogens. Results: The selected LAMP primer set demonstrated high amplification efficiency, successfully detecting as little as 10 attograms (ag) of SFTSV RNA. Moreover, the primer set showed no cross-reactivity with non-SFTSV samples, confirming its high specificity. Conclusion: The developed LAMP assay provides a rapid and reliable method for SFTSV detection, with potential for use in field settings. This diagnostic tool could enhance early detection and improve outbreak response for SFTSV infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.